Bad blood: secrets and lies in a Silicon Valley startup
(Large Print)
Author:
Published:
New York : Random House Large Print, [2018].
Format:
Large Print
Edition:
First large print edition.
Physical Desc:
xii, 541 pages (large print) ; 24 cm
Status:
Copies
Location
Call Number
Status
Last Check-In
Broomfield Non-Fiction
338.7681761 Carre
On Shelf
Jun 2, 2023
Longmont Large Print Nonfiction
Large Type 338.7681 CAR
On Shelf
Mar 11, 2024
Louisville Large Print Non-Fic
LARGE PRINT 338.7681761 CAR
On Shelf
May 17, 2023
Description
The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.
More Copies In Prospector
Loading Prospector Copies...
Reviews from GoodReads
Loading GoodReads Reviews.
Citations
APA Citation (style guide)
Carreyrou, J. (2018). Bad blood: secrets and lies in a Silicon Valley startup. First large print edition. New York, Random House Large Print.
Chicago / Turabian - Author Date Citation (style guide)Carreyrou, John. 2018. Bad Blood: Secrets and Lies in a Silicon Valley Startup. New York, Random House Large Print.
Chicago / Turabian - Humanities Citation (style guide)Carreyrou, John, Bad Blood: Secrets and Lies in a Silicon Valley Startup. New York, Random House Large Print, 2018.
MLA Citation (style guide)Carreyrou, John. Bad Blood: Secrets and Lies in a Silicon Valley Startup. First large print edition. New York, Random House Large Print, 2018.
Note! Citation formats are based on standards as of July 2022. Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy.
Staff View
Grouped Work ID:
baef1559-c66a-350a-94da-a1c38154f67e
Record Information
| Last Sierra Extract Time | Apr 08, 2024 07:45:34 PM |
|---|---|
| Last File Modification Time | Apr 08, 2024 07:45:47 PM |
| Last Grouped Work Modification Time | Apr 18, 2024 01:37:01 AM |
MARC Record
| LEADER | 02587cam 2200457 i 4500 | ||
|---|---|---|---|
| 001 | sky293171414 | ||
| 003 | SKY | ||
| 005 | 20180622000000.0 | ||
| 008 | 180326t20182018nyu edb 001 0 eng d | ||
| 020 | |a 9781984833631 (large print : paperback) | ||
| 020 | |a 1984833634 (large print : paperback) | ||
| 037 | |a BRO-adap20180621-084 | ||
| 040 | |a TEFBT|b eng|e rda|c TEFBT|d TEFBT|d BDX|d OCLCF|d TEFBT|d CLE|d SFR|d SKYRV|d CoBoFLC | ||
| 043 | |a n-us--- | ||
| 082 | 0 | 4 | |a 338.7681761|2 23 |
| 100 | 1 | |a Carreyrou, John,|e author. | |
| 245 | 1 | 0 | |a Bad blood|h [large print] :|b secrets and lies in a Silicon Valley startup /|c John Carreyrou. |
| 250 | |a First large print edition. | ||
| 264 | 1 | |a New York :|b Random House Large Print,|c [2018] | |
| 264 | 4 | |c ©2018 | |
| 300 | |a xii, 541 pages (large print) ;|c 24 cm | ||
| 336 | |a text|b txt|2 rdacontent | ||
| 337 | |a unmediated|b n|2 rdamedia | ||
| 338 | |a volume|b nc|2 rdacarrier | ||
| 340 | |n large print|2 rda | ||
| 504 | |a Includes bibliographical references (pages 457-501) and index. | ||
| 505 | 0 | |a A purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue. | |
| 520 | |a The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers. | ||
| 600 | 1 | 0 | |a Holmes, Elizabeth Anne,|d 1984- |
| 610 | 2 | 0 | |a Theranos (Firm)|x History. |
| 650 | 0 | |a Hematologic equipment industry|z United States. | |
| 650 | 0 | |a New business enterprises|x Corrupt practices|z United States|v Case studies. | |
| 650 | 0 | |a Securities fraud|z United States|v Case studies. | |
| 655 | 7 | |a Large print books.|2 lcgft | |
| 902 | |a 220115 | ||
| 907 | |a .b28684448 | ||
| 945 | |y .i43567174|i R0510393248|l lsnla|s -|h |u 24|x 1|w 0|v 6|t 1|z 180810|1 05-17-2023 19:51|o -|f LARGE PRINT|a 338.7681761|b CAR | ||
| 945 | |y .i4409517x|i R0404862104|l mdnla|s -|h |u 17|x 1|w 0|v 7|t 1|z 190207|1 06-02-2023 19:59|o -|a 338.7681761|b Carre | ||
| 945 | |y .i44440704|i 33060011442899|l lgnla|s -|h |u 20|x 1|w 1|v 6|t 1|z 190531|1 03-11-2024 17:38|o -|a Large Type 338.7681 CAR | ||
| 995 | |a Loaded with m2btab.ltibib in 2023.05 | ||
| 998 | |f -|e z |i eng|h md|h lg|h ls | ||
More Details
Language:
English
ISBN:
9781984833631 (large print : paperback), 1984833634 (large print : paperback)
Notes
Bibliography
Includes bibliographical references (pages 457-501) and index.
Description
The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.
